Healthcare with Confidence
Top TMJ Specialist in Oral Medicine and Oral Oncology
Position: Head, Oral Medicine Unit — Department of Oral and Maxillofacial Surgery
Hospital: Sheba Medical Center, Tel Hashomer
Prof. Noam Yarom is in the Forbes list of the best Israeli doctors. He is one of Israel’s most recognized experts in the field of oral oncology, medication-related osteonecrosis of the jaw – MRONJ, oral mucosal diseases, and supportive care for oncology patients. Professor Noam Yarom has published extensively in leading international journals including Oral Surgery, Oral Medicine, Oral Pathology, Oral Diseases, and Osteoporosis International, with research cited worldwide in the context of bisphosphonate-related osteonecrosis of the jaw and cancer therapy-related oral toxicity.
Qualified Medical Consultation Online, Second Opinion
Ask Doctor
Qualified Medical Consultation of TMJ Expert Noam Yarom in Israel
Oral Oncology
- Oral cancer — diagnosis, early detection, and biopsy of suspicious oral lesions
- Precancerous lesions of the oral cavity — leukoplakia, erythroplakia, oral submucous fibrosis
- Supportive oral care for oncology patients undergoing chemotherapy, radiotherapy, or hematopoietic cell transplantation
- Prevention and management of oral mucositis in cancer patients
Medication-Related Osteonecrosis of the Jaw MRONJ
- Bisphosphonate-related osteonecrosis of the jaw BRONJ — diagnosis, risk assessment, and management
- Denosumab-related osteonecrosis of the jaw
- Prevention protocols for patients on antiresorptive and antiangiogenic therapy
- Collaboration with oncologists, endocrinologists, and maxillofacial surgeons for complex MRONJ cases
Oral Mucosal Diseases
- Recurrent aphthous stomatitis (mouth ulcers)
- Oral lichen planus and lichenoid lesions
- Pemphigus vulgaris and mucous membrane pemphigoid affecting the oral cavity
- Geographic tongue and other benign mucosal conditions
- Burning mouth syndrome
Salivary Gland Disorders
- Xerostomia (dry mouth) — diagnosis and management
- Salivary gland dysfunction — including radiation-induced salivary hypofunction
- Sialadenitis and salivary gland obstruction
Orofacial Pain
- Temporomandibular joint (TMJ) disorders — diagnosis and non-surgical management
- Facial pain of dental and non-dental origin
- Neuropathic orofacial pain
Send Your Medical Files Book Consultation Now
Education of Prof. Noam Yarom
Dental Degree
- DMD (Doctor of Dental Medicine) — Maurice and Gabriela Goldschleger School of Dental Medicine, Tel Aviv University, Israel — Graduated 1999
Specialty Training
- Specialty in Oral Medicine — Tel Aviv University, Israel — Completed 2004
- Training in the Department of Oral Pathology and Oral Medicine, Goldschleger School of Dental Medicine, Tel Aviv University
Professional Experience of TMJ Expert Noam Yarom
- 1999–2004: Residency / Specialty Training in Oral Medicine — Department of Oral Pathology and Oral Medicine, Goldschleger School of Dental Medicine, Tel Aviv University
- 2004 – present: Specialist in Oral Medicine — Department of Oral and Maxillofacial Surgery, Sheba Medical Center, Tel Hashomer
- Current: Head, Oral Medicine Unit — Department of Oral and Maxillofacial Surgery, Sheba Medical Center, Tel Hashomer
- Leads the Oral Medicine Unit — a nationally recognized referral center for complex oral medicine cases
- Works in close interdisciplinary collaboration with the Oral and Maxillofacial Surgery Department, the Oncology Department, and the Dental Medicine Department at Sheba
- Provides specialist consultations for oncology patients at Sheba Medical Center
- Supervises residents and dental students in oral medicine
- Ongoing: Associate Clinical Professor — Department of Oral Pathology and Oral Medicine, Maurice and Gabriela Goldschleger School of Dental Medicine, Tel Aviv University
- Faculty member in oral medicine and oral pathology
- Supervises postgraduate residents and research students
- Ongoing: Session Chair and Scientific Committee Member — Israeli Society of Oral Medicine (ISOM) annual meetings (confirmed ISOM 2024)
Selected Research & Publications of Prof. Yarom
- Yarom N, Yahalom R, Shoshani Y, Hamed W, Regev E, Elad S. “Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome.” Osteoporosis International. 2007 Oct;18(10):1363–70. PMID: 17598065. (Department of Oral Pathology and Oral Medicine, Tel Aviv University)
- Yarom N, Lazarovici TS, Whitefield S, Weissman T, Wasserzug O, Yahalom R. “Rapid onset of osteonecrosis of the jaw in patients switching from bisphosphonates to denosumab.” Oral Surgery Oral Medicine Oral Pathology Oral Radiology. 2018 Jan;125(1):27–30. PMID: 29102242. (Oral Medicine Unit, Sheba Medical Center)
- Khamaisi M, Regev E, Yarom N, Avni B, Leitersdorf E, Raz I, Elad S. “Possible association between diabetes and bisphosphonate-related jaw osteonecrosis.” Journal of Clinical Endocrinology and Metabolism. 2007;92:1172–1175. (cited in multiple international reviews)
- Yarom N, Elad S et al. “Recent advances in cancer therapy-associated oral mucositis.” Oral Diseases (Wiley). 2024 Jul. doi:10.1111/odi.14999. (Goldschleger School of Dental Medicine, Tel Aviv University — co-authored with international group)
- Yarom N et al. (Multiple additional publications on oral mucosal diseases, oral cancer, and supportive oncology care — available on PubMed)
Main Research Areas
- Medication-related osteonecrosis of the jaw MRONJ / BRONJ — bisphosphonates and denosumab
- Oral mucositis in cancer patients — prevention and treatment
- Oral cancer and precancerous lesions — epidemiology and early detection
- Supportive oral care in oncology — chemotherapy and radiotherapy oral toxicities
- Salivary gland dysfunction in cancer patients
- Oral mucosal diseases — lichen planus, pemphigus, aphthous stomatitis
- Risk factors for bisphosphonate-related osteonecrosis (diabetes, type of drug, duration)
Academic Activity
- Faculty member and supervisor of postgraduate oral medicine training at Tel Aviv University
- Regular invited lecturer and session chair at national and international oral medicine and oral oncology conferences
- Chairman, Research Committee — European Association of Oral Medicine (EAOM): responsible for coordinating research activities across European oral medicine centers
- President — International Society of Oral Oncology (ISOO): leads international efforts in oral cancer research, prevention, and treatment guidelines
Professional Memberships & International Roles
- International Society of Oral Oncology ISOO — President
- ISOO is the leading global society dedicated to oral cancer and oncology-related oral medicine
- European Association of Oral Medicine EAOM — Chairman, Research Committee; Former Board Member
- Israeli Association of Oral Medicine — Former Chairman ; current member
- American Academy of Oral Medicine AAOM — Member
- Multinational Association of Supportive Care in Cancer / International Society of Oral Oncology (MASCC/ISOO) — Member
- Israeli Society for Head and Neck Surgery and Oncology — Member
Languages
- Hebrew
- English
Awards & Recognition
- President, International Society of Oral Oncology (ISOO) — one of the highest international positions in the field of oral oncology
- Chairman, Research Committee, European Association of Oral Medicine (EAOM)
- Former Chairman, Israeli Association of Oral Medicine
- Appointed Associate Clinical Professor, Goldschleger School of Dental Medicine, Tel Aviv University
- Heads the Oral Medicine Unit at Sheba Medical Center — the largest hospital in the Middle East, consistently ranked in the Newsweek Top 10 hospitals globally
- PubMed publications cited internationally in MRONJ guidelines and oral oncology reviews
Notable Clinical & Scientific Milestones of Prof. Noam Yarom
- Co-authored one of the early peer-reviewed studies on bisphosphonate-related osteonecrosis of the jaw (BRONJ) from oral bisphosphonate use — published in Osteoporosis International (2007) — contributing to international awareness of this serious complication.
- Published a landmark study on rapid onset of MRONJ in patients switching from bisphosphonates to denosumab — an important safety warning for clinical practice (Oral Surg Oral Med Oral Pathol Oral Radiol, 2018).
- Co-authored a 2024 review on cancer therapy-associated oral mucositis in Oral Diseases — one of the most comprehensive recent reviews on this topic, involving an international expert group.
- As President of ISOO, leads international efforts to develop consensus guidelines for oral cancer screening, early detection, and management of oral complications in cancer patients worldwide.
- The Oral Medicine Unit at Sheba Medical Center under his leadership serves as the national referral center for complex oral medicine cases in Israel, receiving patients from all healthcare funds and hospitals.
